Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis

American Journal of Clinical Pathology

Volumn 133, Issue 1, 2010, Pages 127-132

  Nair, Vidhya ^a   Fischer, Sandra Elisabeth ^b   Adeyi, Oyedele Adewale ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chronic viral hepatitis; Liver biopsy; Nonviral

Indexed keywords

ADOLESCENT; ADULT; AGED; ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; BILE DUCT CARCINOMA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; GRANULOMATOSIS; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER GRANULOMA; LIVER HEMOSIDEROSIS; LIVER METASTASIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCHISTOSOMIASIS; TOXIC HEPATITIS; WILSON DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; FEMALE; FOCAL NODULAR HYPERPLASIA; HEMOSIDEROSIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 73949158484     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP8D7ILBHPSDOK     Document Type: Article

References (11)

1. Lupsor M, Badea R, Stefanescu H, et al. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C: results from a cohort of 324 patients. J Gastrointest Liver Dis. 2008;17:155-163.
2. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol. 2007;102:2589-2600.
3. Lembowicz K, Kryczka W, Walewska-Zielecka B, et al. Wilson's disease coexisting with viral hepatitis type C: a case report with histological and ultrastructural studies of the liver. Ultrastruct Pathol. 1999;23:39-44.
4. Massard J, Ratziu V, Thabut D, et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol. 2006;44(1 suppl):S19-S24.
5. Kryczka W, Zarebska-Michaluk D, Chrapek M. The impact of coexisting diseases on the course of chronic hepatitis C [in Polish]. Przegl Epidemiol. 2005;59:405-410.
6. Kau A, Vermehren J, Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol. 2008;49:634-651.
7. Nachnani JS, Gidwani R, Sadeddin E, et al. Clinicopathological predictors to predict sustained viral response rates in patients with chronic hepatitis C infection. Indian J Gastroenterol. 2007;26:279-282.
8. Levin DM, Baker AL, Riddell RH, et al. Nonalcoholic liver disease: overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med. 1979;66:429-434.
9. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3-16.
10. Ozaras R, Tahan V, Mert A, et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol. 2004;38:449-452.
11. Selmi C, Bowlus CL, Keen CL, et al. Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches. J Med Food. 2007;10:563-565.